Effectiveness of thrombosis prevention with a low molecular weight heparin preparation in gynaecological patients undergoing surgery: an open study.

An open study was carried out in 92 patients to assess the effectiveness of a new low molecular weight heparin in preventing thromboembolic events after gynaecological surgery. The drug was administered subcutaneously 2 hours before the operation and afterwards once a day for 7 days in doses of either 7500 U. aXa/day or 15,000 U.

Combination of tissue polypeptide antigen (TPA) and carcino embryonic antigen (CEA) in different types of cancer.

Tissue polypeptide antigen (TPA) and carcino embryonic antigen (CEA) were measured in 55 patients with cancer in different locations (21 lung cancer, 133 breast cancer, 9 stomach cancer, 5 colorectal cancer, 7 cancer of unknown origin). TPA gives elevated values in all types of cancer. The statistical analysis shows that TPA is about equally sensitive for all cancer types, while CEA has a particularly high sensitivity for colorectal carcinoma.